Skip to content

AngioDynamics ANGO Cash Flow Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
-$8.08M-83.4%-$6.35M+40.9%-$10.9M+14.8%-$6.05M+55.0%-$4.41M+97.7%
$5.59M-11.5%$5.75M-16.3%$6.02M-11.3%$5.83M-14.4%$6.32M-16.0%
$2.68M+11.9%$2.89M+14.4%$4.47M+39.5%$1.64M-13.4%$2.4M-8.2%
-$3.11M+76.4%-$15.91M+12.8%-$13.16M-5.1%
$1.02M-43.5%$422K-47.1%$731K-33.1%$777K+37.3%$1.8M+196%
-$1.51M+52.7%-$1.62M+17.3%-$1.55M+35.5%-$2.62M-$3.19M-111%
$0$0-100%$0-100%
$621K-91.3%$143K+128%-$5.77M-15.4%$7.15M
-$3.83M+59.0%-$17.13M+18.6%-$9.33M-153%
-$4.13M+72.4%-$16.65M+14.0%-$14.96M-13.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does AngioDynamics generate?
AngioDynamics (ANGO) generated -$50.4M in operating cash flow over the trailing twelve months.
What is AngioDynamics's free cash flow?
After $2.9M of capital expenditures, AngioDynamics's free cash flow was -$55.1M over the trailing twelve months, up 26.8% year over year.
Where does AngioDynamics's cash flow data come from?
Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.